Aurinia Pharmaceuticals Inc (AUPH)
4.865
-0.16
(-3.28%)
USD |
NASDAQ |
Apr 25, 16:00
4.865
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Investing (TTM): -6.706M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -6.706M |
September 30, 2023 | -3.467M |
June 30, 2023 | -33.98M |
March 31, 2023 | 17.24M |
December 31, 2022 | -60.63M |
September 30, 2022 | -63.10M |
June 30, 2022 | -45.69M |
March 31, 2022 | -89.64M |
December 31, 2021 | -103.87M |
September 30, 2021 | -79.24M |
June 30, 2021 | -190.93M |
March 31, 2021 | -213.31M |
December 31, 2020 | -158.19M |
September 30, 2020 | -177.36M |
June 30, 2020 | -32.89M |
March 31, 2020 | -8.233M |
December 31, 2019 | 7.783M |
September 30, 2019 | 23.88M |
June 30, 2019 | 17.83M |
March 31, 2019 | 23.85M |
December 31, 2018 | -0.065M |
September 30, 2018 | 70.82M |
June 30, 2018 | -7.982M |
March 31, 2018 | -24.98M |
December 31, 2017 | -8.003M |
Date | Value |
---|---|
September 30, 2017 | -91.93M |
June 30, 2017 | -7.076M |
March 31, 2017 | 3.987M |
December 31, 2016 | 9.991M |
September 30, 2016 | 6.955M |
June 30, 2016 | 7.013M |
March 31, 2016 | 2.944M |
December 31, 2015 | -0.023M |
September 30, 2015 | -0.043M |
June 30, 2015 | -10.08M |
March 31, 2015 | -10.09M |
December 31, 2014 | -10.08M |
September 30, 2014 | -10.08M |
June 30, 2014 | -0.096M |
March 31, 2014 | -0.096M |
December 31, 2013 | -0.036M |
September 30, 2013 | -0.0268M |
June 30, 2013 | -0.0005M |
March 31, 2013 | 0.8888M |
December 31, 2012 | -0.0312M |
September 30, 2012 | -0.1064M |
June 30, 2012 | -0.0493M |
March 31, 2012 | -0.9202M |
December 31, 2011 | -1.151M |
September 30, 2011 | -1.029M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-213.31M
Minimum
Mar 2021
23.88M
Maximum
Sep 2019
-63.18M
Average
-45.69M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
Lexaria Bioscience Corp | -0.1991M |
Acasti Pharma Inc | -1.452M |
Edesa Biotech Inc | 0.00 |
Xenon Pharmaceuticals Inc | -117.17M |
ESSA Pharma Inc | 6.200M |